Cardiawave
Paris
About Cardiawave
Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the team at the Langevin Institute, a world leader in ultrasound imaging and therapy, and the team at the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging. Led by an experienced management team, 2017 Prizewinner of Worldwide Innovation Contest 3rd phase, Cardiawave has secured over €14m since inception, to develop its product and to pursue preclinical studies before first-in-man expected in 2019.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Last round: Grant (Jan 2019)
- Website: cardiawave.com
- Phone: +33 (0) 1 55 26 82 16
Industries & Categories
Collaboration, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cardiawave-115019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.